Vaccine countdown update: 20 Nov - our Bonkers Bargain attracts interest
Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full acquisition. Read on for our thoughts on this and other updates here.
Fusion Antibodies: results underwhelm
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREE
More on Advanced Medical Solutions
Odd name but great results | Director buying | Retailer woes
News covered here includes our assessment of excellent results from a provider of a diverse range…
Episode 9 of the Investor’s Champion Podcast
This episode discusses Bitcoin's surging price, the UK competition authority's probe into the veterinary sector, Trainline's growth and…
More on Argentex Group PLC
Bonkers Bargains: new team, new plan and firmer footing
A new management team has concluded its strategic revew and has a bold plan to accelerate…
Episode 4 of the Investor’s Champion Podcast
In this episode of the Investor’s Champion Podcast, Chris and Lee run through key news from…
More on Frasers Group
Has Nike been caught flat-footed?
Our portfolio company covered here dominates the market for athletic footwear, but is it the best…
Bonkers Bargain Mulberry still looks interesting
Having experienced a dramatic rise and fall over the past decade, Mulberry faces an uncertain future.…
More on Fusion Antibodies PLC
Vaccine countdown update: 20 Nov - our Bonkers Bargain attracts interest
Mike Ashley’s Frasers has upped its stake in Mulberry and is obliged to contemplate a full…
Coronavirus impact: 28 April - soaring share prices from this little lot
Announcements included an update from from Burford Capital, which saw its shares bounce strongly, but we still…
